Bone loss and/or pain associated with an elevated activation of osteoclasts is prevented, treated and/or alleviated by the administration of an effective amount of a compound capable of inhibiting the activity of peptidylarginine deiminase (PAD) enzymes. Methods and compounds for this use are disclosed, as well as diagnostic methods and kits.